Expanding human papillomavirus vaccination to high-risk mid-adults may be cost-effective
1. In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when ...
Tag: oropharyngeal cancer
#VisualAbstract: Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer
Click here to read this study in JAMA Otolaryngology-Head and Neck Surgery. ©2023 2 Minute Medicine, Inc. All rights reserved. No works ...
#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma
Click to read this study in JAMA Otolaryngology - Head & Neck Surgery.
#VisualAbstract: Taxane monotherapy may be more effective for patients with recurrent or metastatic head and neck cancer and prior nivolumab exposure
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Incidence of HPV-associated oropharyngeal carcinoma expected to increase for older adults between 2020-2045
Click to read this study in JAMA Oncology.
#VisualAbstract: Head and neck cancers are highly prevalent among alcohol consumption-associated malignancies in the global population
Click to read the study in The Lancet Oncology.
#VisualAbstract: Primary surgical treatment is effective for human papillomavirus-negative oropharyngeal carcinoma with T1-2 staging
Click to read this study in Otolaryngology - Head and Neck Surgery.
#VisualAbstract: Induction chemotherapy with docetaxel, cisplatin, and cetuximab offers similar outcomes with a potentially more favorable treatment schedule than 5-fluorouracil
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Pembrolizumab plus cetuximab shows early clinical efficacy for patients with recurrent or metastatic head and neck squamous cell carcinoma
Click to read the study in The Lancet Oncology.
#VisualAbstract: Definitive chemoradiotherapy and surgical treatment are equally effective primary interventions for patients with advanced oroparyngeal squamous cell carcinoma
Click to read the study in JAMA Network Open.